Aquestive Therapeutics AQST
NASDAQ AQST
$4.13 +0.05 (+1.23%)
At close: Oct 22, 2026 · 4:00 PM EDT

Aquestive Therapeutics (AQST) EV to FCF (2023)

Updated

Aquestive Therapeutics' (AQST) EV to FCF stood at 12.92 in Q3 2023, up 80.5% from the prior quarter.

Analysis

Aquestive Therapeutics (AQST) EV to FCF (2023) Analysis & Trends

On a TTM basis, Aquestive Therapeutics' EV to FCF came in at 0.10 as of Sep 30, 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Aquestive Therapeutics 514.98 Mn 55.52 Mn 9.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 12.92
Jun 30, 2023 7.16
Mar 31, 2023 2.94
API Access

Aquestive Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=AQST&period=max&api_key=YOUR_API_KEY